JFFCX | RBMTX | JFFCX / RBMTX | |
Total Expense Ratio | 1.41 | 1.48 | 95% |
Annual Report Gross Expense Ratio | 1.49 | 1.48 | 101% |
Fund Existence | 14 years | 16 years | - |
Gain YTD | 7.943 | 11.260 | 71% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500 | 250 | 200% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.98B | 27B | 7% |
Annual Yield % from dividends | 1.20 | 0.20 | 587% |
Returns for 1 year | 13.00 | 15.71 | 83% |
Returns for 3 years | 27.29 | 32.73 | 83% |
Returns for 5 years | 29.37 | 37.29 | 79% |
Returns for 10 years | 54.07 | 79.27 | 68% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ARKF | 52.64 | 1.68 | +3.30% |
ARK Fintech Innovation ETF | |||
SBIO | 33.15 | 0.46 | +1.39% |
ALPS Medical Breakthroughs ETF | |||
RFG | 50.41 | 0.56 | +1.11% |
Invesco S&P MidCap 400® Pure Growth ETF | |||
LFAE | 115.57 | 0.83 | +0.73% |
LifeX 2048 Longevity Income ETF | |||
ESMV | 28.79 | -0.06 | -0.21% |
iShares ESG Optd MSCI USA Min Vol FacETF |